How Life Sciences Companies Can Build Resilience Amid Economic and Geopolitical Volatility

Tariffs, shifting trade routes and supply chain disruptions are reshaping risk for life sciences companies. Here’s how insurers are helping clients adapt. The post How Life Sciences Companies Can Build Resilience Amid Economic and Geopolitical Volatility appeared first on Risk & Insurance.

Commercial risk teams are responding with tighter controls, scenario modeling, and broader collaboration across underwriting, claims, and cyber operations.

Leaders continue to prioritize resilience planning while balancing cost, coverage terms, and operational exposure in a changing market cycle.